Seres Therapeutics Inc (MCRB)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Eric D. Shaff
Employees:
330
200 SIDNEY STREET, CAMBRIDGE, MA 02139
617 945 9626

Seres Therapeutics, Inc. engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection. SER-155, a cultivated bacteria microbiome drug, is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases.

Data derived from most recent annual or quarterly report
Market Cap 148.717 Million Shares Outstanding128.205 Million Avg 30-day Volume 5.548 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.49
Price to Revenue2.3997 Debt to Equity-6.6875 EBITDA-130.093 Million
Price to Book Value0.0 Operating Margin-107.4884 Enterprise Value235.152 Million
Current Ratio2.706 EPS Growth0.598 Quick Ratio2.145
1 Yr BETA 0.8152 52-week High/Low 7.3 / 0.91 Profit Margin-111.0315
Operating Cash Flow Growth46.1133 Free Cash Flow to Firm (FCFF) TTM -126.396 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score-3.5313
View SEC Filings from MCRB instead.

View recent insider trading info

Seres Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MCRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MCRB

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-10-31 by CLOGHESSY PAULA
  • 4: filed on 2023-10-31 by SHAFF ERIC D.
  • 4: filed on 2023-10-31 by YOUNG TERESA L.
  • 4: filed on 2023-10-31 by ARKOWITZ DAVID
  • 4: filed on 2023-10-31 by DESROSIER THOMAS
  • 4: filed on 2023-10-31 by EGE DAVID S.
  • 4: filed on 2023-10-31 by VON MOLTKE LISA
  • 4: filed on 2023-10-31 by HENN MATTHEW R.
  • 4: filed on 2023-06-23 by BIONDI PAUL
  • 4: filed on 2023-06-23 by AUSIELLO DENNIS A

    • Events (8k)

  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-28:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    34.8 Thousand total shares from 8 transactions

    Exercise Derivative Conversion (M)

    113.1 Thousand total shares from 8 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ARKOWITZ DAVID CHIEF FINANCIAL OFFICER

    • Officer
    		 175,756 2023-10-27 3

    DESROSIER THOMAS CHIEF LEGAL OFFICER AND EVP

    • Officer
    		 113,891 2023-10-27 2

    SHAFF ERIC D. CEO AND PRESIDENT

    • Officer
    • Director
    		 115,620 2023-10-27 2

    CLOGHESSY PAULA SEE REMARKS

    • Officer
    		 45,684 2023-10-27 2

    HENN MATTHEW R. SEE REMARKS

    • Officer
    		 56,356 2023-10-27 3

    VON MOLTKE LISA SEE REMARKS

    • Officer
    		 9,513 2023-10-27 2

    YOUNG TERESA L. SEE REMARKS

    • Officer
    		 8,454 2023-10-27 2

    EGE DAVID S. SEE REMARKS

    • Officer
    		 66,991 2023-10-27 3

    DERE WILLARD H

    • Director
    		 0 2023-06-22 1

    KENDER RICHARD N

    • Director
    		 0 2023-06-22 1

    AUSIELLO DENNIS A

    • Director
    		 0 2023-06-22 1

    FRASER CLAIRE

    • Director
    		 0 2023-06-22 3

    GRAVES KURT

    • Director
    		 0 2023-06-22 1

    BEHAR GREGORY

    • Director
    		 0 2023-06-22 1

    BIONDI PAUL

    • Director
    		 0 2023-06-22 1

    BERENSON STEPHEN

    • Director
    		 0 2023-06-22 1

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    FLAGSHIP PIONEERING INC.

    AFEYAN NOUBAR

    • 10% Owner
    		 23,493,063 2022-07-05 0

    ZAUSNER MERYL

    • Director
    		 31,746 2022-07-05 0

    FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VII, L.P.

    • 10% Owner
    		 5,825,495 2022-07-05 0

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 14,754,820 2021-05-17 0

    CHAPMAN MARCUS SEE REMARKS

    • Officer
    		 0 2021-02-04 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    FLAGSHIP PIONEERING INC.

    FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VI, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 15,049,991 2020-11-23 0

    AUNINS JOHN G. CHIEF TECHNOLOGY OFFICER & EVP

    • Officer
    		 0 2020-01-29 0

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 21,586,905 2019-06-18 0

    FLAGSHIP PIONEERING INC.

    FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VI, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    • 10% Owner
    		 4,444,444 2019-06-18 0

    POMERANTZ ROGER

    • Director
    		 0 2019-06-13 0

    KIM LORENCE H.

    • Director
    		 0 2019-06-13 0

    COOK DAVID N SEE REMARKS

    • Officer
    		 147,435 2019-01-26 0

    HORGAN KEVIN CHIEF MEDICAL OFFICER AND EVP

    • Officer
    		 0 2019-01-25 0

    TRUCKSIS MICHELE SEE REMARKS

    • Officer
    		 4,893 2018-01-26 0

    HASHAD WAEL EVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2017-01-26 0

    HUTT PETER BARTON

    • Director
    		 0 2016-06-15 0

    AFEYAN NOUBAR

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURELABS IV, LLC

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    KANIA EDWIN M JR

    • Director
    • 10% Owner
    		 14,641,852 2016-05-25 0

    NESTLE HEALTH SCIENCE US HOLDINGS, INC.

    NESTLE SA

    NIMCO US, INC.

    • 10% Owner
    		 6,888,888 2015-07-01 0

    AFEYAN NOUBAR

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    KANIA EDWIN M JR

    • Director
    • 10% Owner
    		 14,682,876 2015-06-25 0

    CAUTREELS WERNER

    • Director
    		 0 2015-06-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HENN MATTHEW R. - Officer SEE REMARKS

    		2023-10-31 21:36:37 -0400 2023-10-30 S 3,886 $1.35 d 56,356 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    VON MOLTKE LISA - Officer SEE REMARKS

    		2023-10-31 21:36:59 -0400 2023-10-30 S 4,232 $1.35 d 9,513 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    CLOGHESSY PAULA - Officer SEE REMARKS

    		2023-10-31 21:43:04 -0400 2023-10-30 S 2,904 $1.35 d 45,684 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    EGE DAVID S. - Officer SEE REMARKS

    		2023-10-31 21:39:07 -0400 2023-10-30 S 4,066 $1.35 d 66,991 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    SHAFF ERIC D. - Director - Officer CEO AND PRESIDENT

    		2023-10-31 21:40:56 -0400 2023-10-30 S 8,552 $1.35 d 115,620 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    DESROSIER THOMAS - Officer CHIEF LEGAL OFFICER AND EVP

    		2023-10-31 21:39:10 -0400 2023-10-30 S 4,156 $1.35 d 113,891 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    ARKOWITZ DAVID - Officer CHIEF FINANCIAL OFFICER

    		2023-10-31 21:39:11 -0400 2023-10-30 S 4,066 $1.35 d 175,756 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    YOUNG TERESA L. - Officer SEE REMARKS

    		2023-10-31 21:40:54 -0400 2023-10-30 S 2,907 $1.35 d 8,454 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    CLOGHESSY PAULA - Officer SEE REMARKS

    		2023-10-31 21:43:04 -0400 2023-10-27 M 9,418 d 9,417 direct yes

    CLOGHESSY PAULA - Officer SEE REMARKS

    		2023-10-31 21:43:04 -0400 2023-10-27 M 9,418 a 48,588 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    SHAFF ERIC D. - Director - Officer CEO AND PRESIDENT

    		2023-10-31 21:40:56 -0400 2023-10-27 M 27,838 d 27,837 direct yes

    SHAFF ERIC D. - Director - Officer CEO AND PRESIDENT

    		2023-10-31 21:40:56 -0400 2023-10-27 M 27,838 a 124,172 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    YOUNG TERESA L. - Officer SEE REMARKS

    		2023-10-31 21:40:54 -0400 2023-10-27 M 11,361 d 11,360 direct yes

    YOUNG TERESA L. - Officer SEE REMARKS

    		2023-10-31 21:40:54 -0400 2023-10-27 M 11,361 a 11,361 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    ARKOWITZ DAVID - Officer CHIEF FINANCIAL OFFICER

    		2023-10-31 21:39:11 -0400 2023-10-27 M 13,209 d 13,209 direct yes

    ARKOWITZ DAVID - Officer CHIEF FINANCIAL OFFICER

    		2023-10-31 21:39:11 -0400 2023-10-27 M 13,209 a 179,822 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    DESROSIER THOMAS - Officer CHIEF LEGAL OFFICER AND EVP

    		2023-10-31 21:39:10 -0400 2023-10-27 M 13,501 d 13,500 direct yes

    DESROSIER THOMAS - Officer CHIEF LEGAL OFFICER AND EVP

    		2023-10-31 21:39:10 -0400 2023-10-27 M 13,501 a 118,047 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    EGE DAVID S. - Officer SEE REMARKS

    		2023-10-31 21:39:07 -0400 2023-10-27 M 11,361 d 11,360 direct yes

    EGE DAVID S. - Officer SEE REMARKS

    		2023-10-31 21:39:07 -0400 2023-10-27 M 11,361 a 71,057 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    VON MOLTKE LISA - Officer SEE REMARKS

    		2023-10-31 21:36:59 -0400 2023-10-27 M 13,745 d 13,744 direct yes

    VON MOLTKE LISA - Officer SEE REMARKS

    		2023-10-31 21:36:59 -0400 2023-10-27 M 13,745 a 13,745 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    HENN MATTHEW R. - Officer SEE REMARKS

    		2023-10-31 21:36:37 -0400 2023-10-27 M 12,623 d 12,622 direct yes

    HENN MATTHEW R. - Officer SEE REMARKS

    		2023-10-31 21:36:37 -0400 2023-10-27 M 12,623 a 60,242 direct yes -35.2778 -27.7778 0.0 1 -35.2778 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SERES THERAPEUTICS INC MCRB 2023-11-28 22:15:04 UTC 4.8151 0.5049 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 21:45:03 UTC 4.8151 0.5049 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 21:15:04 UTC 4.8151 0.5049 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 20:45:04 UTC 4.8151 0.5049 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 20:15:04 UTC 4.8205 0.4995 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 19:45:03 UTC 4.8205 0.4995 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 19:15:04 UTC 4.8162 0.5038 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 18:45:03 UTC 4.8162 0.5038 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 18:15:03 UTC 4.8162 0.5038 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 17:45:04 UTC 4.8125 0.5075 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 17:15:04 UTC 4.8125 0.5075 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 16:45:04 UTC 4.8125 0.5075 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 16:15:04 UTC 4.8125 0.5075 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 15:45:03 UTC 4.8108 0.5092 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 15:15:03 UTC 4.8108 0.5092 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 14:45:04 UTC 4.8071 0.5129 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 14:15:04 UTC 4.8071 0.5129 1300000
    SERES THERAPEUTICS INC MCRB 2023-11-28 13:45:04 UTC 4.8087 0.5113 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 13:15:03 UTC 4.8087 0.5113 1200000
    SERES THERAPEUTICS INC MCRB 2023-11-28 12:45:04 UTC 4.8087 0.5113 1200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund MCRB -3489.0 shares, $-82863.75 2021-01-31 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund MCRB -9884.0 shares, $-63455.28 2022-09-30 N-PORT
    ALLSPRING FUNDS TRUST- Allspring U.S. Long/Short Equity Fund MCRB -9682.0 shares, $-46570.42 2023-07-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund MCRB -12700.0 shares, $-30226.0 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments